Board Members
Paul Evans is a Managing Partner of Ironbridge Capital and has been on the Board since iNova's formation in December 2006. Paul is the current Chairman of iNova.
Greg Minton is a Managing Partner of Archer Capital and has been on the Board since iNova's formation in December 2006.
John Russell is a Director at Ironbridge Capital and has been on the Board since iNova's formation in December 2006
Ben Frewin is an Investment Director at Archer Capital and has been on the Board since iNova's formation in December 2006.
Andrew Howden is the Chief Executive Officer of iNova Pharmaceuticals and has been on the Board since August 2008
Chris van Niekerk is the Chief Operating Officer of iNova Pharmaceuticals and has been on the Board since August 2008.
Norbert Walther is the Chief Financial Officer of iNova Pharmaceuticals and has been on the Board since January 2009.
DURO-TUSS range of products provide effective relief of dry and chesty coughs
Difflam range of products relieve painful conditions of the mouth and throat.
A range of allergy medications designed to relieve different allergy symptoms.